Market Cap : 2.67 B | Enterprise Value : 2.23 B | PE Ratio : 26.79 | PB Ratio : 5.09 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Corcept Therapeutics's Accounts Payable for the quarter that ended in Dec. 2020 was $10.6 Mil.
Corcept Therapeutics's quarterly Accounts Payable increased from Jun. 2020 ($6.3 Mil) to Sep. 2020 ($6.5 Mil) and increased from Sep. 2020 ($6.5 Mil) to Dec. 2020 ($10.6 Mil).
Corcept Therapeutics's annual Accounts Payable declined from Dec. 2018 ($8.3 Mil) to Dec. 2019 ($7.5 Mil) but then increased from Dec. 2019 ($7.5 Mil) to Dec. 2020 ($10.6 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
No Headline